Scotland strikes CF drug deal with Vertex, rest of UK still ...

Patients in Scotland will gain access to Vertex’s cystic fibrosis drugs Orkambi and Symkevi, after the company signed an access agreement with health officials.

Xeris’ severe low blood sugar pen gets FDA approval

Pharma stocks fall after Pelosi's plan to cut drug prices em...

Pharma stocks fell yesterday after an early draft of House Speaker Nancy Pelosi’s plan to reduce drug prices was made public, which could curb prices on the 250 most expensive drugs.

Novartis' Kymriah okayed for funding in Scotland for lymphom...

Novartis’ Kymriah has become the first CAR-T available to NHS patients across the UK after Scotland’s medicines cost-effectiveness body recommended funding in an aggressive form of lymphoma

Alexion’s biosimilar-blocking EU patent play for Soliris fai...

NHS funds eye gene therapy, after Novartis cuts £613,000 pri...

NICE has recommended the NHS should fund Novartis’ Luxturna for a rare eye disorder, after the company agreed a discount from the list price of more than £613,000 per patient.